PG08: Disorders Of Female Pubertal Development
Time:8:15 am - 5:00 pm
Location:Room 3 - San Diego Convention Center
Jennifer E. Dietrich, M.S., M.Sc. (Chair), Baylor College of Medicine
Samantha M. Pfeifer, M.D., University of Pennsylvania Medical School
Elisabeth H. Quint, M.D., University of Michigan
Beth W. Rackow, M.D., Columbia University
Developed in Cooperation with the Pediatric and Adolescent Gynecology Special Interest Group
NEEDS ASSESSMENT AND COURSE DESCRIPTION
The last few decades have seen physicians across many disciplines caring for more children, adolescents and young women in their childbearing years. Due to changes in population growth, variation in patterns of disease, trauma statistics and effects of the environment, as well as increased prevalence rates of chronic conditions, such as childhood cancer, cystic fibrosis and diabetes mellitus, knowledge of long-term risks is important. Because ovarian function may be altered based on patterns of events, a broad understanding of pubertal effects is needed. In addition, understanding the long-term ramifications of early puberty in the child versus delayed puberty in the adolescent is important in the care of these patients once matured to adulthood. Finally, with the advent of in vitro fertilization techniques and continued advancements in the field of reproductive medicine, an understanding of pubertal effects spanning generations, is also critical.
Aimed at physicians, nurses and other healthcare professionals whose practices include pediatric and adolescent girls, this course will focus on issues regarding female puberty. Topics to be addressed include evaluation and treatment of precocious puberty; structural anomalies, hormones and genetics and their relation to delayed puberty; and the management of puberty in the developmentally delayed patient. Interesting cases will also be presented for discussion.
At the conclusion of this course, participants should be able to:
- Identify specific risk conditions and situations leading to precocious pubertal development in the female child and genetic tendencies leading to delayed puberty.
- Identify “normal” precocity, as may frequently be the case in precocious adrenarche, versus pathologic pubertal progression and expected constitutional delay versus pathologic delay.
- Discuss generational effects of pubertal alteration and pubertal outcomes of children who were products of IVF and reproductive technologies.
- Describe the evaluation and management of precocious puberty and of delayed puberty.
- Summarize the unique challenges the provider is faced with in caring for the developmentally delayed patient of pubertal age.